Regulatory Science on Novel Coronavirus Disease

Abstract

At the 2020 annual meeting of The Society of Risk Analysis Japan, we hosted a special session focusing on novel coronavirus disease (COVID-19) as an emerging risk. In the context of the COVID-19 pandemic, the regulatory science perspective is very important as countermeasures have to be decided in a very limited time and without sufficient scientific knowledge. The objective of the session was to discuss the contribution of risk science to countermeasures against COVID-19. The topics were as follows: (1) science and policy under the risk governance; (2) risk assessment at mass gathering events; (3) regulatory science of the infection risk management and the regulatory framework issue; (4) comparison of mortality risk and economic impact.